We included three patients with diffuse large B‐cell lymphoma (DLBCL), treated with anti‐CD19 CAR T‐cell therapy, that developed ICANS and in which longitudinal MRI scans were available. The gene discussed is CD19; the disease is diffuse large B-cell lymphoma.